MedTrace Logo

Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study

NCT02152657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2017-04-26

No results posted yet for this study

Summary

The purpose of this study is to analyze the safety and efficacy of mesenchymal stem cell transplantation through percutaneous injection in patients with chronic spinal cord injury.

Conditions

  • Spinal Cord Injury

Interventions

OTHER

Mesenchymal stem cell transplantation

Mesenchymal stem cell transplantation through percutaneous injection.

Sponsors & Collaborators

  • Hospital Sao Rafael

    lead OTHER

Principal Investigators

  • Ricardo R dos Santos, MD, PhD · Hospital São Rafael

  • Milena BP Soares, PhD · Hospital São Rafael

  • Bruno SF Souza, MD, Msc · Hospital São Rafael

  • Ticiana F Larocca, MD, Msc · Hospital São Rafael

  • Rodrigo L Alves, MD, PhD · Hospital São Rafael

  • Yuri MA Souza, MD · Hospital São Rafael

  • André C Matos, MD · Hospital São Rafael

  • Cristiane F Villarreal, PhD · Hospital São Rafael

  • Alexandre S Carvalho-da-Silva, Student · Hospital São Rafael

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02152657 on ClinicalTrials.gov